BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 27069158)

  • 21. A prospective randomized study comparing open versus laparoscopy-assisted D2 radical gastrectomy in advanced gastric cancer.
    Cai J; Wei D; Gao CF; Zhang CS; Zhang H; Zhao T
    Dig Surg; 2011; 28(5-6):331-7. PubMed ID: 21934308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thinking of the application of membrane anatomy in gastric cancer surgery after neoadjuvant therapy].
    Zhao DB; Zhang XJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(7):657-660. PubMed ID: 32683826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrectomy and lymphadenectomy for gastric cancer: is the pancreas safe?
    Herbella FA; Tineli AC; Wilson JL; Del Grande JC
    J Gastrointest Surg; 2008 Nov; 12(11):1912-4. PubMed ID: 18612707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Novel treatment strategy using Trafermin® consisting of bFGF for intractable pancreatic fistula following gastrectomy for gastric cancer-a case report with literature reviews].
    Kasuga M; Komatsu S; Ikoma H; Ichikawa D; Okamoto K; Shiozaki A; Fujiwara H; Murayama Y; Kuriu Y; Nakanishi M; Ochiai T; Kokuba Y; Otsuji E
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):1966-8. PubMed ID: 22202254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative pancreatic fistula formation according to ISGPF criteria after D2 gastrectomy in Western patients.
    Kung CH; Lindblad M; Nilsson M; Rouvelas I; Kumagai K; Lundell L; Tsai JA
    Gastric Cancer; 2014; 17(3):571-7. PubMed ID: 24105422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
    Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
    Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
    Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk factors of postoperative complication after total gastrectomy in advanced gastric cancer patients receiving neoadjuvant chemotherapy].
    Cui H; Zhang KC; Cao B; Deng H; Liu GX; Cui JX; Xie TY; Liang WQ; Zhang QP; Wang N; Chen L; Wei B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):153-159. PubMed ID: 33508921
    [No Abstract]   [Full Text] [Related]  

  • 29. [Safety and feasibility of gastrectomy after neoadjuvant chemotherapy for gastric cancer].
    Aoyama T; Hayashi T; Fujikawa H; Ogata T; Cho H; Wada H; Kitani Y; Yukawa N; Oshima T; Rino Y; Ozawa Y; Masuda M; Yoshikawa T
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1621-2. PubMed ID: 24393868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for post-operative pulmonary complications after gastrectomy for gastric cancer.
    Inokuchi M; Kojima K; Kato K; Sugita H; Sugihara K
    Surg Infect (Larchmt); 2014 Jun; 15(3):314-21. PubMed ID: 24796353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Best time to administer coagulation factor XIII( Fibrogammin P) for postoperative intractable pancreatic fistula following gastrectomy for gastric cancer].
    Shoda K; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Arita T; Konishi H; Murayama Y; Shiozaki A; Kuriu Y; Ikoma H; Nakanishi M; Fujiwara H; Otsuji E
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2307-9. PubMed ID: 24394094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery.
    Kaito A; Kinoshita T; Shitara K; Shibasaki H; Nishida T
    Eur J Surg Oncol; 2017 Apr; 43(4):801-807. PubMed ID: 28187877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Neoadjuvant Chemotherapy Toxicity and Postoperative Complications on Short-term and Long-term Outcomes After Curative Resection of Gastric Cancer.
    Wu C; Wang N; Zhou H; Wang T; Mao Q; Zhang X; Zhao D
    J Gastrointest Surg; 2020 Jun; 24(6):1278-1289. PubMed ID: 31140064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of a simple predictive scoring system for pancreatic fistula after laparoscopy-assisted gastrectomy.
    Miyai H; Hara M; Hayakawa T; Takeyama H
    Dig Endosc; 2013 Nov; 25(6):585-92. PubMed ID: 23461800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term outcomes of gastrectomy after neoadjuvant chemotherapy for clinical stage III gastric cancer: propensity score-matched analysis of a multi-institutional database.
    Umeda S; Kanda M; Nakanishi K; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Shimizu D; Kobayashi D; Tanaka C; Fujiwara M; Murotani K; Kodera Y
    Surg Today; 2021 May; 51(5):821-828. PubMed ID: 33170366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of laparoscopic gastrectomy with radical lymph node dissection for gastric cancer: from a viewpoint of pancreas-related complications.
    Obama K; Okabe H; Hosogi H; Tanaka E; Itami A; Sakai Y
    Surgery; 2011 Jan; 149(1):15-21. PubMed ID: 20627337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.
    Sasako M; Sano T; Yamamoto S; Kurokawa Y; Nashimoto A; Kurita A; Hiratsuka M; Tsujinaka T; Kinoshita T; Arai K; Yamamura Y; Okajima K;
    N Engl J Med; 2008 Jul; 359(5):453-62. PubMed ID: 18669424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An advanced bipolar device helps reduce the rate of postoperative pancreatic fistula in laparoscopic gastrectomy for gastric cancer patients: a propensity score-matched analysis.
    Shibao K; Honda S; Adachi Y; Kohi S; Kudou Y; Matayoshi N; Sato N; Hirata K
    Langenbecks Arch Surg; 2022 Dec; 407(8):3479-3486. PubMed ID: 36181517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bursectomy and non-bursectomy D2 gastrectomy for advanced gastric cancer, initial experience from a single institution in China.
    Zhang WH; Chen XZ; Yang K; Liu K; Chen ZX; Zhang B; Zhou ZG; Hu JK
    World J Surg Oncol; 2015 Dec; 13():332. PubMed ID: 26643472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer.
    Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Terashima M
    Ann Surg Oncol; 2013 May; 20(5):1575-83. PubMed ID: 23076557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.